Skip to content

RETINALGENIX TECHNOLOGIES INC.

RTGN

CIK 0001836295

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$2.4M
+43.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.12
+45.8% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$44
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
18.84M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings